医学分子生物学杂志 ›› 2023, Vol. 20 ›› Issue (6): 487-492.doi: 10.3870/j.issn.1672-8009.2023.06.004

• 论著 • 上一篇    下一篇

白桦脂酸对 RANKL 诱导的 MC3T3-E1 细胞成骨分化的影响及机制研究 #br#

  

  1. 绵阳市骨科医院足踝科 四川省绵阳市, 621000
  • 出版日期:2023-11-30 发布日期:2023-12-28
  • 基金资助:
    四川省卫生和计划生育委员会普及应用项目 (No. 17PJ207)

Effect of Betulinic Acid on RANKL Induced Osteoblast Differentiation of MC3T3-E1 Cells and Its Mechanism #br#

  1. Department of Foot and Ankle, Mianyang Orthopeadic Hospital, Mianyang, Sichuan, 621000, China
  • Online:2023-11-30 Published:2023-12-28

摘要: 目的 观察白桦脂酸 (betulinic acid, BA) 对核因子 κB 受体活化因子配体 ( receptor activator ofnuclear factor-κb ligand, RANKL) 诱导的小鼠前成骨细胞系 ( MC3T3-E1) 成骨分化的影响, 并探讨其机制方法 体外培养 MC3T3-E1 细胞, 采用不同浓度 (0、 5、 10、 20 μmol / L) BA 培养 48 h, 采用 CCK-8实验检测 MC3T3-E1 细胞增殖能力将实验分为 Control 、 RANKL 、 RANKL + BA 、 RANKL + BA +740Y-P (PI3K 激动剂) 组及 RANKL + BA + Curcumin (MEK / ERK 激动剂) 采用 ELISA 法检测白介素-6 (IL-6) 水平; 碱性磷酸酶 ( alkaline phosphatase, ALP) 活性检测试剂盒测定 ALP 活性; 蛋白质印迹检测成骨标记蛋白骨钙蛋白 ( osteocalcin, OCN)、 骨桥蛋白 ( osteopontin, OPN)、 Collagen Ⅰ 、 p-P65、 P65以及 MEK / ERK PI3K 信号通路蛋白表达结果 BA (5、 10 μmol / L) MC3T3 细胞无明显毒性。 10μmol / L BA 预处理显著减少 RANKL 诱导的 IL-6 生成及 p-P65 / P65 比值 ( P< 0. 05)。 10 μmol / L BA 能明显逆转 RANKL 诱导的 OCN、 OPN、 Collagen Ⅰ 蛋白表达下调 ( P< 0. 05)。 10 μmol / L BA 能明显抑制 MEK、ERK、 PI3K 磷酸化 (P< 0. 05)。 10 μmol / L BA 显著增加成骨标记蛋白 OCN、 OPN、 Collagen Ⅰ 蛋白表达,提高 APL 染色阳性率及活性, 其作用被 MEK / ERK 激动剂姜黄素和 PI3K 激动剂 740Y-P 明显削弱 ( P <0. 05)。 结论 BA 通过抑制 NF-κB 活化及 IL-6 的分泌, 改善炎症微环境, 同时抑制 MEK / ERK PI3K 通路, 促进成骨分化

关键词: 骨质疏松, 白桦脂酸, 成骨细胞分化, 核因子 κB, 白细胞介素 6

Abstract: Objective To observe the effect of betulinic acid ( BA) on receptor activator ofnuclear factor-κb ligand ( RANKL) induced osteoblast differentiation in preosteoblast cell line(MC3T3-E1), and to explore its possible mechanism. Methods MC3T3-E1 cells were cultured invitro with treatment of different concentrations (0, 5, 10, 20 μmol / L) of BA for 48 h. The proliferation of MC3T3-E1 was detected by CCK-8. Cells were divided into 5 groups. Control group, RANKL group, RANKL + BA group, RANKL + BA + 740Y-P (PI3K agonist) group and RANKL + BA + Curcumin (MEK / ERK agonist) group. The level of interleukin-6 (IL-6) in cell supernatant was detected by ELISA. The activity of alkaline phosphatase (ALP) was detected by ALP activity detection kit. The expression levels of osteocalcin (OCN), osteopontin (OPN), Collagen I, p-P65, P65, MEK / ERK and PI3K signaling pathway proteins were detected by Western blotting. Results BA of 5 μmol / L and 10 μmol / L was of no significant toxicity to MC3T3 cells. Thepretreatment with 10 μmol / L BA could significantly reduce the level of IL-6 and the ratio of p-P65 /P65 which were induced by RANKL (P < 0. 05). The down-regulation of OCN, OPN, Collagen I proteins induced by RANKL were significantly reversed by treatment of 10 μmol / L BA (P < 0. 05).10 μmol / L BA could obviously inhibit the phosphorylation of MEK, ERK and PI3K ( P < 0. 05). 10 μmol / L BA could significantly increase the expression levels of osteogenic marker proteins(OCN, OPN, Collagen I), and could increase the positive rate and activity of APL staining. Theabove effects were significantly weakened by the MEK / ERK agonist curcumin and PI3K agonist740Y-P (P< 0. 05). Conclusion BA can improve the inflammatory micro-environment by inhibiting NF-κB activation and IL-6 secretion, and can promote the osteoblast differentiation through inhibition of MEK / ERK and PI3K pathways.

Key words:

osteoporosis, betulinic acid, osteoblast differentiation, nuclear factor kappa B, interleukin-6

中图分类号: